In this article, we will explore the fascinating life and work of Edward John Wherry III, an individual who has left an indelible mark on history. From his humble beginnings to his lasting impact on today's world, Edward John Wherry III has been the subject of admiration, study and controversy. Throughout these pages, we will delve into his legacy, exploring his influence in various fields, his role in crucial moments in history, and the lessons we can draw from his experience. Prepare for an exciting journey through the life and contributions of Edward John Wherry III, and discover why his story continues to resonate in our hearts and minds.
Edward John Wherry III (known professionally as John Wherry) is an American immunologist. He is the Richard and Barbara Schiffrin President's Distinguished Professor and department chair of Systems Pharmacology and Translational Therapeutics at the University of Pennsylvania. He is also the director of the Penn Institute for Immunology.
E. John Wherry III | |
---|---|
Academic background | |
Alma mater | Penn State University Thomas Jefferson University Emory University |
Doctoral advisor | Laurence Eisenlohr |
Academic work | |
Discipline | Immunology |
Institutions | University of Pennsylvania Wistar Institute |
Website | https://www.med.upenn.edu/wherrylab/ |
Wherry received his B.S. degree in science from The Pennsylvania State University in 1993 and his Ph.D. in immunology from Thomas Jefferson University in 2000. He completed his thesis on the effect of epitope density on CD8+ cell priming under the mentorship of Laurence "Ike" Eisenlohr.
Wherry continued on to a postdoctoral fellowship with Rafi Ahmed at Emory University from 2000 to 2004. After completing his postdoc, he joined The Wistar Institute as an assistant professor where he remained until 2010. He then joined the department of Microbiology at the University of Pennsylvania's Perelman School of Medicine. He served as the chair of the Immunology Graduate Group (IGG) from 2011 to 2013 and remains on the IGG Executive Committee. In 2012 he was appointed as director of the Institute for Immunology (IFI). Wherry was named the inaugural Richard and Barbara Schiffrin President's Distinguished Professor in 2017. A year later, Wherry was appointed as chair of the Systems Pharmacology and Translational Therapeutics department.
Wherry's research has focused on the field of T cell exhaustion, elucidating mechanisms that attenuate T cell responses during chronic infections and cancer. His discoveries include characterizing several immunological checkpoints and T cell states that can be targeted to re-invigorate exhausted T cells. Wherry's lab has played a prominent role in understanding the concept of human immune health using high-dimensional, integrative, translational immunology approaches.